Adds prescription digital therapeutics to Medicare Part B and to the list of items covered under Medicaid beginning January 1, 2026. Requires the Department of Health and Human Services to create a new Medicare payment framework with coding, payment rules, manufacturer reporting, confidentiality protections, and penalties, with specific deadlines for a payment methodology and product-specific codes.

Establishes manufacturer reporting obligations starting January 1, 2026, and gives CMS 1 year to set an initial payment methodology and 2 years to issue HCPCS codes for individual products; Medicaid coverage is updated to reference the new statutory definition of prescription digital therapeutics.